Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	38.28	254.32	171.48
Short-Term Investments	-	20.27	120.35
Trading Asset Securities	234.96	-	20.34
Cash & Short-Term Investments	273.24	274.6	312.17
Cash Growth	-0.50%	-12.04%	-
Accounts Receivable	22.45	22.2	6.09
Other Receivables	15.24	12.24	3.54
Receivables	37.69	34.43	9.63
Inventory	35.33	24.8	28.37
Total Current Assets	346.26	333.83	350.17
Property, Plant & Equipment	309.55	129.53	16.63
Long-Term Investments	50.89	20	-
Long-Term Deferred Tax Assets	5.87	9.42	24.78
Other Long-Term Assets	43.26	68.76	29.38
Total Assets	755.82	561.54	420.96
Accounts Payable	15.78	2.8	3.11
Accrued Expenses	52.52	37.12	15.83
Current Portion of Long-Term Debt	23.12	9.6	48.45
Current Portion of Leases	1.51	1.44	0.87
Current Income Taxes Payable	5.08	-	0.01
Current Unearned Revenue	8.05	0.26	1.98
Other Current Liabilities	76.02	65.82	19.84
Total Current Liabilities	182.07	117.04	90.09
Long-Term Debt	26.62	31.92	35.95
Long-Term Leases	5.62	7.14	6.91
Long-Term Unearned Revenue	0.17	0.2	0.23
Total Liabilities	214.49	156.3	133.18
Common Stock	67.21	67.21	67.21
Retained Earnings	254.59	118.51	1.06
Comprehensive Income & Other	219.53	219.53	219.51
Shareholders' Equity	541.33	405.25	287.78
Total Liabilities & Equity	755.82	561.54	420.96
Total Debt	56.88	50.09	92.18
Net Cash (Debt)	216.36	224.51	219.99
Net Cash Growth	-3.63%	2.05%	-
Net Cash Per Share	3.22	3.34	3.42
Filing Date Shares Outstanding	67.21	67.21	64.27
Total Common Shares Outstanding	67.21	67.21	64.27
Working Capital	164.19	216.79	260.09
Book Value Per Share	8.05	6.03	4.48
Tangible Book Value	541.33	405.25	287.78
Tangible Book Value Per Share	8.05	6.03	4.48
Machinery	25.87	24.51	19.76
Construction In Progress	263.2	80.08	-
Leasehold Improvements	3.09	2.72	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.